Pharma launch analytics: How to compress the first 90 days and win the three years that follow
A new analytics platform has been developed to help pharmaceutical companies compress the first 90 days of a commercial launch and improve market access over the next three years. This platform leverages machine learning and data analytics to provide real-time insights and predictive modeling, enabling companies to optimize their launch strategies and improve market share. By compressing the first 90 days, companies can accelerate revenue growth and improve long-term market access.
⚡ Key Takeaways
- The platform uses a combination of machine learning and data analytics to provide real-time insights and predictive modeling.
- The platform can help pharmaceutical companies compress the first 90 days of a commercial launch by up to 30%.
- The platform provides predictive modeling to identify high-value targets and optimize launch strategies.
- The platform integrates with existing CRM systems to provide a seamless user experience.
- The platform requires a minimum of 6 months of historical data to provide accurate predictive modeling.
This platform has the potential to revolutionize the way pharmaceutical companies launch new products, enabling them to accelerate revenue growth and improve long-term market access. By compressing the first 90 days, companies can gain a significant competitive advantage and improve their market share.
✅ Practical Steps
- Implement the platform's predictive modeling capabilities to identify high-value targets and optimize launch strategies.
- Integrate the platform with existing CRM systems to provide a seamless user experience.
- Use the platform's real-time insights to inform launch decisions and adjust strategies accordingly.
Want the full story? Read the original article.
Read on Databricks Blog ↗